N-(1-Oxopentyl)-N-[[2’-(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-L-valine valsartan 137862-53-4 Diovan CGP 48933 CGP-48933 Prexxartan (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine NSC-758927 80M03YXJ7I L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- CHEBI:9927 DTXSID6023735 DAFIRO COMPONENT VALSARTAN COPALIA COMPONENT VALSARTAN EXFORGE COMPONENT VALSARTAN IMPRIDA COMPONENT VALSARTAN ENTRESTO COMPONENT VALSARTAN VALTURNA COMPONENT VALSARTAN DAFIRO-HCT COMPONENT VALSARTAN COPALIA-HCT COMPONENT VALSARTAN IMPRIDA-HCT COMPONENT VALSARTAN (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid valsartanum (S)-N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-methyl)-valine N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine (2S)-3-methyl-2-(N-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)pentanamido)butanoic acid (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid 48933, CGP RefChem:6344 C09CA03 DTXCID801508574 (2S)-3-Methyl-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)butanoic acid N-pentanoyl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-L-valine Tareg Provas (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid MFCD00865840 L-Valsartan N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- CHEMBL1069 137863-60-6 C24H29N5O3 Nisis N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE Kalpress Miten Vals N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine (2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid Valzaar Valtan [3H]valsartan (2S)-3-Methyl-2-(pentanoyl{[2?-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}amino)butanoic acid (2~{S})-3-methyl-2-[pentanoyl-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid SMR000466318 Diovan (TN) UNII-80M03YXJ7I Valpression Valsartana Varexan Valsartan CRS Valtan; HSDB 7519 Valsartan [USAN:USP:INN:BAN] U35 valsartan (Diovan) Valsartan (Standard) Spectrum_001796 VALSARTAN [INN] VALSARTAN [JAN] VALSARTAN [MI] VALSARTAN [HSDB] VALSARTAN [USAN] Spectrum2_001120 Spectrum3_001831 Spectrum4_000749 Spectrum5_001582 VALSARTAN [VANDF] VALSARTAN [MART.] EC 604-045-2 SCHEMBL2542 VALSARTAN [USP-RS] VALSARTAN [WHO-DD] BSPBio_003501 GTPL593 KBioGR_001078 KBioSS_002289 VALSARTAN [EMA EPAR] MLS000759423 MLS001424088 BIDD:GT0345 SCHEMBL678231 SPECTRUM1505209 SPBio_001260 Valsartan - Bio-X trade mark Valsartan (JP18/USP/INN) GTPL3937 orb1300528 orb3141240 VALSARTAN [EP IMPURITY] VALSARTAN [ORANGE BOOK] SCHEMBL29406387 VALSARTAN [EP MONOGRAPH] Valsartan, >=98% (HPLC) KBio2_002287 KBio2_004855 KBio2_007423 KBio3_003006 EZR-104 VAL-489 VALSARTAN [USP MONOGRAPH] ACWBQPMHZXGDFX-QFIPXVFZSA-N GLXC-05207 HMS1922L21 HMS2051L12 HMS2093K22 HMS2232F05 HMS3651E04 HMS3715P12 Pharmakon1600-01505209 ALBB-038653 CGP48933 MSK10065 AGSAV301 COMPONENT VALSARTAN BDBM50049186 EBC-11260 HY-18204R NSC758927 s1894 Valsartan for system suitability CRS DIOVAN HCT COMPONENT VALSARTAN Valsartan for peak identification CRS AKOS015914315 AKOS015994698 EXFORGE HCT COMPONENT VALSARTAN AC-4543 CCG-101028 CCG-221275 CS-1967 DB00177 DS-1248 FV28662 KS-1194 NC00278 NSC 758927 (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine NCGC00178027-08 NCGC00178027-11 NCGC00178027-19 BV164506 HY-18204 SBI-0206738.P001 SW197658-2 V0112 D00400 AB00639940-06 AB00639940-08 AB00639940_09 AB00639940_11 EN300-6482022 F036602 F794020 Q155472 SR-05000001928 SR-05000001928-1 BRD-K45158365-001-02-3 BRD-K45158365-001-05-6 BRD-K45158365-001-10-6 BRD-K45158365-001-11-4 Z1379303659 Valsartan Working Standard (Secondary Reference Standard) Valsartan, European Pharmacopoeia (EP) Reference Standard Valsartan, United States Pharmacopeia (USP) Reference Standard N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid (2S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid (S)-2-(N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; (S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
Mostrar todos os 202 sinônimos 
